Shorted
Nanosonics logo
NAN
Health Care Equipment & Services

Nanosonics

Short interest
6.68%
−0.83 pp 30d
as of 9 Oct 2026
Reported shorts
20M
Shares on issue
299.168M

Nanosonics (NAN) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Positive
1d ago

What Did Nanosonics (ASX:NAN) Win for Its CORIS System?

Highlights Endoscope cleaning platform earned a gold award at a national design competition Product is due to launch commercially, adding a next platform beside its flagship Market sentiment has been cautious, with estimates trimmed after the latest result Nanosonics (ASX:NAN), the Sydney-based infection prevention group best known for its trophon ultrasound probe disinfector, won a gold award in the medical and scientific product design category at the Australian Good Design Awards for its C...

Continue reading
Kalkine
Neutral
7 Oct

How Is Nanosonics (ASX:NAN) Preparing for Its CORIS Launch?

Highlights Nanosonics is inside the launch window it set for the commercial release of its CORIS endoscope cleaning system in the UK, Ireland and Australia, with the US to follow. The infection prevention company has flagged higher operating costs to support the rollout while its established trophon business continues to fund growth. The shares firmed in late September alongside other device makers, although they remain lower over the past year. Nanosonics (ASX:NAN) has entered October inside...

Continue reading
Kalkine
Neutral
28 Sept

Why is Nanosonics (ASX:NAN) bouncing as its CORIS launch nears?

Highlights The infection prevention specialist has rebounded from a steep slide as healthcare attracts defensive flows. Its core ultrasound probe disinfection franchise keeps growing while a second platform heads into commercial launch. US tariffs, a firmer Australian dollar and heavier launch spending will shape margins over the months ahead. Nanosonics (ASX:NAN) has started to claw back ground after a bruising year for the stock, with a strong session last week putting it among the better-p...

Continue reading
Kalkine
Positive
25 Sept

Is Nanosonics (ASX:NAN) Regaining Ground Before CORIS Launches?

Highlights Infection control group bounced with healthcare peers this week On-market capital management continues after a sharp slide Endoscope cleaning launch is the next big test Nanosonics (ASX:NAN) has clawed back some lost ground this week, with the infection prevention company's shares jumping on Monday alongside larger healthcare peers while it continues daily updates on its on-market capital management program. A Welcome Bounce The Sydney-based maker of the trophon ultrasound probe di...

Continue reading
Kalkine
Neutral
23 Sept

What could NAN (ASX:NAN) Reveal After Its Latest Update?

Highlights NAN has released a fresh company disclosure centred on an update to its share repurchase programme. The announcement provides a current corporate event for readers tracking NAN within the broader Technical Analysis category. The latest update remains an event-led development, with further company communication needed for additional context. NAN has entered the latest Australian market-news cycle with a fresh corporate disclosure centred on an update to its share repurchase pro...

Continue reading
Kalkine
Neutral
18 Sept

Nanosonics Executes Buy-Back of 100,000 Shares on September 17 Under $40 Million FY27 On-Market Program

Nanosonics Limited (ASX:NAN) announced a daily buy-back update confirming the acquisition of 100,000 fully paid ordinary shares on 17 September 2026, with a total expenditure of AUD $290,260.00. This purchase is part of the company’s on-market share buy-back initiative capped at $40 million for the fiscal year 2027. Key Points On 17 September 2026, Nanosonics repurchased 100,000 ordinary fully paid NAN shares for AUD $290,260.00 in total The highest share price paid that day was AUD $2.92, ...

Continue reading
Kalkine
Neutral
11 Sept

What Is New for Nanosonics Limited (ASX:NAN) in ASX Smallcap Stocks?

Highlights The latest completed ASX session placed Nanosonics Limited and its most recent financial update in current market context. The release is being assessed against execution, liquidity and funding discipline across smaller ASX businesses. Execution, funding discipline, and transparent disclosure remain central to the interpretation of the latest corporate development. During the latest completed ASX session, Nanosonics Limited (ASX:NAN) remained linked with its most recent financial u...

Continue reading
Kalkine
Neutral
13 Aug

Why Nanosonics (ASX:NAN) Could Be Worth Watching in Penny Stocks Now?

Highlights Nanosonics sits at the intersection of broader Australian market signals and business milestones. Demand composition, not just demand direction, matters for understanding the company story. Execution across commercial traction, costs and capital allocation can separate company performance from sector momentum. A broad market headline can hide very different company realities. For Nanosonics (ASX:NAN), the more useful reading starts with business milestones, then moves through fundi...

Continue reading
Kalkine
Neutral
20 July

Why Is Infection-prevention specialist Nanosonics (ASX:NAN) Turning Heads Right Now?

Highlights Healthcare devices and corporate travel offered contrasting windows into the ASX mid-cap segment this week. Nanosonics and Corporate Travel Management show how mid-sized names can pair recurring revenue with cyclical recovery. Market participants are watching installed-base growth, travel demand and margins across the two companies. Infection-prevention specialist Nanosonics (ASX:NAN), the maker of a widely used device that disinfects ultrasound probes in hospitals and clinics, drew ...

Continue reading
Kalkine
Neutral
8 July

Nanosonics (ASX:NAN) Chart Signals Base Formation As Breakout Watch Intensifies

Highlights Nanosonics is forming an inverse head-and-shoulders pattern following an extended corrective phase. The neckline aligns with a long-term descending trendline, creating an important technical level. Chart watchers are monitoring for confirmation that could indicate a transition toward a more constructive trend. Nanosonics Ltd (ASX:NAN), a healthcare technology company specialising in infection prevention and decontamination solutions, has moved back onto the...

Continue reading